DnB Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $23.7M | Buy |
|
|||||
|
2025
Q2 | $23.3M | Sell |
|
|||||
|
2025
Q1 | $22.9M | Sell |
|
|||||
|
2024
Q4 | $24.3M | Buy |
|
|||||
|
2024
Q3 | $20.9M | Buy |
|
|||||
|
2024
Q2 | $21.7M | Buy |
|
|||||
|
2024
Q1 | $18.8M | Sell |
|
|||||
|
2023
Q4 | $18.5M | Buy |
|
|||||
|
2023
Q3 | $16.8M | Buy |
|
|||||
|
2023
Q2 | $20.9M | Buy |
|
|||||
|
2023
Q1 | $16.7M | Sell |
|
|||||
|
2022
Q4 | $15.3M | Buy |
|
|||||
|
2022
Q3 | $14.6M | Buy |
|
|||||
|
2022
Q2 | $15M | Buy |
|
|||||
|
2022
Q1 | $16.2M | Sell |
|
|||||
|
2021
Q4 | $20.1M | Buy |
|
|||||
|
2021
Q3 | $16.9M | Buy |
|
|||||
|
2021
Q2 | $10.7M | Sell |
|
|||||
|
2021
Q1 | $12.2M | Buy |
|
|||||
|
2020
Q4 | $10.3M | Buy |
|
|||||
|
2020
Q3 | $7.83M | Buy |
|
|||||
|
2020
Q2 | $5.11M | Buy |
|
|||||
|
2020
Q1 | $4.22M | Sell |
|
|||||
|
2019
Q4 | $5.88M | Buy |
|
|||||
|
2019
Q3 | $4.94M | Buy |
|
|||||
|
2019
Q2 | $3.84M | Sell |
|
|||||
|
2019
Q1 | $4.32M | Sell |
|
|||||
|
2018
Q4 | $3.79M | Sell |
|
|||||
|
2018
Q3 | $4.54M | Sell |
|
|||||
|
2018
Q2 | $3.89M | Buy |
|
|||||
|
2018
Q1 | $3.52M | Buy |
|
|||||
|
2017
Q4 | $2.65M | Buy |
|
|||||
|
2017
Q3 | $2.43M | Sell |
|
|||||
|
2017
Q2 | $2.7M | Sell |
|
|||||
|
2017
Q1 | $2.3M | Buy |
|
|||||
|
2016
Q4 | $1.89M | Buy |
|
|||||
|
2016
Q3 | $2.22M | Buy |
|
|||||
|
2016
Q2 | $1.8M | Sell |
|
|||||
|
2016
Q1 | $2.01M | Buy |
|
|||||
|
2015
Q4 | $1.43M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.44M | Buy |
|
|||||
|
2013
Q4 | $1.87M | Buy |
|
|||||
|
2013
Q3 | $1.91M | Buy |
|
|||||
|
2013
Q2 | $1.2M | Buy |
|